Total assets decreased 25.0%
Total assets changed -25.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed -25.0% from the comparable as-filed period.
Capital expenditure changed -80.4% from the comparable as-filed period.
Free-cash-flow margin changed +9127 basis points from the comparable as-filed period.
Operating cash-flow margin changed +9120 basis points from the comparable as-filed period.
Inventory / revenue changed -156 basis points from the comparable as-filed period.
Shares outstanding changed +0.7% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Capex / revenue changed -7 basis points from the comparable as-filed period.
SBC / revenue changed -63 basis points from the comparable as-filed period.
Stock-based compensation changed -116.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Selling, general & administrative changed +0.3% from the comparable as-filed period.
Inventory / revenue changed -918 basis points from the comparable as-filed period.
Revenue changed -15.5% from the comparable as-filed period.
Cash & equivalents changed +1282.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Capital expenditure changed -63.0% from the comparable as-filed period.
Free-cash-flow margin changed +918 basis points from the comparable as-filed period.
Operating cash-flow margin changed +902 basis points from the comparable as-filed period.
Shares outstanding changed +0.5% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
SBC / revenue changed +99 basis points from the comparable as-filed period.
Total assets changed +1.2% from the comparable as-filed period.
Selling, general & administrative changed +10.9% from the comparable as-filed period.
Capex / revenue changed -16 basis points from the comparable as-filed period.
Stock-based compensation changed +166.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.